Earkart Completes US FDA Registration for Its Hearing Aids
Earkart secured active US FDA device listings across four hearing aid categories, including prescription and OTC hearing aids.
Key Takeaways
- Earkart completed US FDA establishment registration, announced on November 18, 2026.
- It holds active device listings across four hearing aid categories.
- The categories are prescription, OTC, wireless prescription and wireless OTC hearing aids.
- Earkart says registration and listing are not FDA approval or clearance.
- Earkart said it plans to explore partnerships and distribution opportunities in the US.
Table of Contents 6 sections
Earkart Limited, an Indian hearing aid maker, has completed its US Food and Drug Administration (FDA) establishment registration and secured active medical device listings across four hearing aid categories. The company announced the step on November 18, 2026.
Earkart said its listed portfolio covers prescription hearing aids, over-the-counter (OTC) hearing aids, wireless prescription hearing aids and wireless OTC hearing aids. The company's release states that establishment registration and device listing are not FDA approval, clearance or endorsement, and that each product remains subject to FDA rules.
Earkart's US FDA registration at a glance
| Detail | Value |
|---|---|
| Company | Earkart Limited |
| What it completed | US FDA establishment registration |
| Device listings | Active listings across four hearing aid categories |
| Categories | Prescription, OTC, wireless prescription and wireless OTC hearing aids |
| Announced | November 18, 2026 |
| Is it FDA approval? | No, the company says registration and listing are not approval or clearance |
Earkart makes hearing aids and remote hearing test equipment
Earkart develops, manufactures and distributes hearing aids and audiology equipment. Its products include behind-the-ear (BTE) and receiver-in-canal (RIC) hearing aids, along with Earkart OMNI, a machine for remote hearing tests. The company makes its hearing aids at a plant in Noida, Uttar Pradesh, and its Managing Director is Rohit Misra.
The company was incorporated in 2021. Its Rs 49.26 crore SME IPO, which included an offer for sale by promoter Rohit Misra, was priced at Rs 135 per share, and its shares listed on the BSE SME platform in October 2025.
| When | What happened |
|---|---|
| 2021 | Earkart Limited is incorporated |
| September 25 to 29, 2025 | SME IPO of Rs 49.26 crore at Rs 135 per share is open for bids |
| October 3, 2025 | Shares list on the BSE SME platform |
| November 18, 2026 | Completes US FDA establishment registration with listings in four hearing aid categories |
Earkart's management on the US milestone
"Completing our U.S. FDA establishment registration and securing active device listings across four hearing aid categories is an important milestone in Earkart's international growth journey."
What Earkart says it plans for the US market
Earkart said it intends to offer its own branded hearing aids to US consumers at affordable prices. The company said it plans to explore partnerships, distribution opportunities and market-entry strategies in the US, using its own product development and manufacturing capabilities.
In its release, Earkart cited Emergen Research figures that put the US hearing aids market at $4.65 billion in 2026, growing to $9.57 billion by 2035 at an annual growth rate of 8.4%.
Where Earkart stands after its FDA registration
Earkart, a BSE SME listed hearing aid maker incorporated in 2021, now holds US FDA establishment registration and active device listings in four hearing aid categories. The company has said it plans to explore partnerships and distribution opportunities in the US.
More news
Frequently Asked Questions
What is Earkart?
What did Earkart announce?
Is Earkart's registration an FDA approval?
How many hearing aid categories did Earkart list with the FDA?
Which hearing aid categories are in Earkart's FDA listings?
How does Earkart plan to enter the US market?
How does Earkart plan to price its hearing aids in the US?
How big is the US hearing aids market according to Earkart's release?
What products does Earkart make?
Where does Earkart make its hearing aids?
Who is Earkart's Managing Director?
Is Earkart a listed company?
More in Startups
FirstClub Posts Rs 97.5 Crore Loss on Rs 64 Crore Revenue in FY26
FirstClub lost Rs 97.5 crore on Rs 64 crore of operating revenue in FY26, its first year.
Cashify Turns Profitable in FY26 With About Rs 6.5 Crore Profit
Cashify posted a net profit of about Rs 6.5 crore in FY26 as its revenue grew 50%.
PB Fintech's Alok Bansal to Leave Executive Role in March 2027
PB Fintech co-founder Alok Bansal will step down as Executive Vice Chairman on 31 March 2027.
